Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Developmental toxicity evaluation of diethyl and dimethyl phthalate in rats

View through CrossRef
AbstractDiethyl phthalate (DEP) and dimethyl phthalate (DMP), phthalic acid ester (PAE) plasticizers, were evaluated for developmental toxicity because of reports in the literature that some PAE were embryotoxic and teratogenic. A previous study (Singh et al., '72) suggested that an increased incidence of skeletal defects in rats might result from gestational exposure to DEP (0.6–1.9 g/kg) or DMP (0.4–1.3 g/kg), ip, on gestational days (gd) 5, 10, and 15. In the current study DEP (0, 0.25, 2.5, and 5%) or DMP (0, 0.25, 1, and 5%) in feed (approximately 0.2–4.0 g/kg/day) were supplied to timed‐mated rats from gd 6 to 15. Treatment with 5% DMP resulted in increased relative maternal liver weight. Also, animals exhibited reduced body weight gain during treatment (5% DEP or DMP) and during gestation (5% DEP). Weight gain corrected for gravid uterine weight was also reduced in animals fed 5% DEP. However, high‐dose treatment with either DEP or DMP resulted in changes in food and water consumption paralleling the body weight reductions, suggesting that apparent toxic effects on maternal body weight may reflect PAE/feed unpalatability. Treatment with 2.5% DEP resulted in only transient changes in body weight during early treatment. The only maternal effects at 0.25 or 1% DMP were minor changes in food and/or water consumption, and there were no effects at 0.25% DEP. Thus, the NOAELs for maternal toxicity were 1% DMP and 0.25% DEP. In contrast to the observed maternal toxicity, there was no effect of DEP or DMP treatment on any parameter of embryo/fetal development, except an increased incidence of supernumerary ribs (a variation) in the 5% DEP group. These results do not support the conclusion of other investigators that DEP and DMP are potent developmental toxicants. Rather, they suggest that the shortchain PAE are less developmentally toxic than PAE with more complex substitution groups, e.g., di(2‐ethylhexyl) phthalate, mono(2‐ethylhexyl) phthalate, and butyl benzyl phthalate. © 1993 Wiley‐Liss, Inc.
Title: Developmental toxicity evaluation of diethyl and dimethyl phthalate in rats
Description:
AbstractDiethyl phthalate (DEP) and dimethyl phthalate (DMP), phthalic acid ester (PAE) plasticizers, were evaluated for developmental toxicity because of reports in the literature that some PAE were embryotoxic and teratogenic.
A previous study (Singh et al.
, '72) suggested that an increased incidence of skeletal defects in rats might result from gestational exposure to DEP (0.
6–1.
9 g/kg) or DMP (0.
4–1.
3 g/kg), ip, on gestational days (gd) 5, 10, and 15.
In the current study DEP (0, 0.
25, 2.
5, and 5%) or DMP (0, 0.
25, 1, and 5%) in feed (approximately 0.
2–4.
0 g/kg/day) were supplied to timed‐mated rats from gd 6 to 15.
Treatment with 5% DMP resulted in increased relative maternal liver weight.
Also, animals exhibited reduced body weight gain during treatment (5% DEP or DMP) and during gestation (5% DEP).
Weight gain corrected for gravid uterine weight was also reduced in animals fed 5% DEP.
However, high‐dose treatment with either DEP or DMP resulted in changes in food and water consumption paralleling the body weight reductions, suggesting that apparent toxic effects on maternal body weight may reflect PAE/feed unpalatability.
Treatment with 2.
5% DEP resulted in only transient changes in body weight during early treatment.
The only maternal effects at 0.
25 or 1% DMP were minor changes in food and/or water consumption, and there were no effects at 0.
25% DEP.
Thus, the NOAELs for maternal toxicity were 1% DMP and 0.
25% DEP.
In contrast to the observed maternal toxicity, there was no effect of DEP or DMP treatment on any parameter of embryo/fetal development, except an increased incidence of supernumerary ribs (a variation) in the 5% DEP group.
These results do not support the conclusion of other investigators that DEP and DMP are potent developmental toxicants.
Rather, they suggest that the shortchain PAE are less developmentally toxic than PAE with more complex substitution groups, e.
g.
, di(2‐ethylhexyl) phthalate, mono(2‐ethylhexyl) phthalate, and butyl benzyl phthalate.
© 1993 Wiley‐Liss, Inc.

Related Results

Exposure of preterm neonates receiving total parenteral nutrition to phthalates and its impact on neurodevelopment at the age of 2 months
Exposure of preterm neonates receiving total parenteral nutrition to phthalates and its impact on neurodevelopment at the age of 2 months
AbstractThis prospective study assessed the exposure to phthalates of preterm neonates who received total parenteral nutrition (TPN) during their stay in the neonatal intensive car...
Seasonal variation and health risk indices of phthalate esters in Asa River, Ilorin
Seasonal variation and health risk indices of phthalate esters in Asa River, Ilorin
Water remains polluted due to increasing anthropogenic and industrial activities. Phthalate esters (PAEs) are one of the most frequently detected persistent organic pollutants in t...
Esters of Mono‐, Di‐, and Tricarboxylic Acids
Esters of Mono‐, Di‐, and Tricarboxylic Acids
AbstractThis chapter presents information on esters of mono‐, di‐, and tricarboxylic acids with monoalcohols from 1 to over 10 carbons in either a straight chain or branched config...
Prenatal phthalate exposure and cord blood DNA methylation
Prenatal phthalate exposure and cord blood DNA methylation
Abstract The indiscriminate use of phthalate-containing products in daily life can adversely affect pregnant women and their children. Phthalate can modify DNA methylation ...
Phthalate exposure in Thai children and adolescents
Phthalate exposure in Thai children and adolescents
Abstract Background Phthalates are found in products made of plastic. Because of concerns regarding the hazards of phthal...
Exposure to Phthalates and Cardiovascular Diseases with type 2 Diabetes
Exposure to Phthalates and Cardiovascular Diseases with type 2 Diabetes
Abstract Purpose Cardiovascular disease (CVD) results in more than half of the mortality and the majority of morbidity in patients with type 2 diabetes. We aim to evaluate ...

Back to Top